ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 264

Specialized Footwear Decreases Medial Tibial Bone Mineral Density Over 48 Weeks in Knee Osteoarthritis

Justin B. Gan1, Laura E. Thorp2, Roy H. Lidtke3, Rachel A. Mikolaitis3, Louis F. Fogg4, Joel A. Block3 and Najia Shakoor1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Anatomy and Cell Biology, Rush University Medical Center, Chicago, IL, 3Section of Rheumatology, Rush University Medical Center, Chicago, IL, 4Department of Nursing, Rush University Medical Center, Chicago, IL

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Bone density and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose:   Osteoarthritis (OA) is characterized by increased subchondral bone mineral density at affected joints.  In the knee, proximal tibial bone mineral density (BMD) is associated with dynamic joint loading (Thorp et al, Bone, 2006), and thereby serves as a marker for structural consequences of sustained altered joint loading.  Biomechanical interventions such as specialized footwear (the mobility shoe) have been shown to reduce joint load in knee OA.  We hypothesized that load reduction with use of the mobility shoe would yield appreciable reductions in proximal tibial BMD over 48 weeks.

Methods: Subjects with mild to moderate medial compartment radiographic knee OA were randomized to wear either the mobility shoe or “non-flexible” control shoe.  All participants and investigators were blind to treatment group allocation.  Participants were asked to wear the shoes 6 hours per day at least 6 days per week.  Subjects underwent DXA scanning of bilateral knees at baseline and at 24 and 48 weeks after starting the intervention.  These scans were evaluated in a blinded manner by a trained investigator using a previously validated method. The BMD of the medial and lateral regions of the tibial plateau were measured in each knee.  Repeated measures ANOVA (rm-ANOVA) was used to evaluate changes in BMD over time in each group.

Results: Nine subjects in the mobility shoe group and 13 subjects in the control group had BMD data available at all three time points (0, 24, and 48 weeks).  The mobility shoe group demonstrated a significant reduction in the medial proximal tibial BMD of the affected knee from 0 to 24 to 48 weeks (p=0.01, see Table).  The control shoe group did not demonstrate a statistically significant reduction in medial proximal tibial BMD over this time (see Table).   There were no significant changes in lateral tibial BMD in either group from 0 to 24 to 48 weeks (see Table).

Conclusion: The mobility shoe yielded a significant reduction in medial tibial BMD over 48 weeks of use.  A control walking shoe did not yield similar BMD changes.   These results suggest that use of the mobility shoe can lead to potentially beneficial structural changes in subchondral bone as the result of a dynamic load reducing intervention.

 

Control Shoe (n=13)

Mobility Shoe (n=9)

Medial Tibial BMD (g/cm2) *

 

 

Week 0

0.850 ± 0.138

0.836 ± 0.116

Week 24

0.848 ± 0.183

0.818 ± 0.121

Week 48

0.851 ± 0.137

0.790 ± 0.092

rm-ANOVA, p-value

p=0.979

p=0.01

Lateral Tibial BMD (g/cm2) *

 

 

Week 0

0.669 ± 0.119

0.681 ± 0.132

Week 24

0.688 ± 0.091

0.690 ± 0.133

Week 48

0.699 ± 0.116

0.691 ± 0.145

rm-ANOVA, p-value

p=0.267

p=0.466

*Values are the mean ± SD unless otherwise indicated; BMD, bone mineral density; rm-ANOVA, repeated measures ANOVA.


Disclosure:

J. B. Gan,
None;

L. E. Thorp,
None;

R. H. Lidtke,

Shoe patent,

9;

R. A. Mikolaitis,
None;

L. F. Fogg,
None;

J. A. Block,
None;

N. Shakoor,

Shoe patent,

9.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/specialized-footwear-decreases-medial-tibial-bone-mineral-density-over-48-weeks-in-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology